Efficacy of Bezlotoxumab Against Clostridioides difficile Infection: A Case-Series Study at a University Hospital in Japan and Literature Review

Background Clostridioides difficile infection (CDI) recurrence is a public health concern as well as a health economic burden. Bezlotoxumab treatment is one way to prevent recurrence; however, its clinical results have not been reported in Japan. Therefore, we investigated the efficacy and safety of...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori, Nobuaki, Hirai, Jun, Asai, Nobuhiro, Mikamo, Hiroshige
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Gastroenterology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469635/
https://www.ncbi.nlm.nih.gov/pubmed/37664309
http://dx.doi.org/10.7759/cureus.42779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469635/
https://www.ncbi.nlm.nih.gov/pubmed/37664309
http://dx.doi.org/10.7759/cureus.42779

Ejemplares similares